Uncategorized
VIDEO: No significant increase in IOP after Iluvien implant, studies find
HONOLULU — Jim C. Lai, MD, discusses safety data from the PALADIN and USER studies evaluating IOP rise after treatment with Iluvien (fluocinolone acetonide intravitreal implant, Alimera Sciences) at the Association for Research in Vision and Ophthalmology meeting here.